Target intelligence / Profile preview

Tooth hydroxyapatite (HAP)

Target
HAP
Molecular classification
Other (Inorganic mineral, Calcium phosphate mineral)
01

Overview

Tooth hydroxyapatite is the principal inorganic mineral component of human dental enamel and dentin, comprising 70–95% of their mass. It is a crystalline calcium phosphate compound with the chemical formula Ca₁₀(PO₄)₆(OH)₂. Hydroxyapatite provides the hardness and structural resiliency of teeth, forming densely packed rods (and interrods) surrounded by a small organic matrix and water[2][4][5]. Enamel hydroxyapatite is highly resistant to mechanical wear but vulnerable to acidic dissolution (demineralization) during caries and erosion. Remineralization therapies—including toothpastes and dental treatments—sometimes employ biomimetic or synthetic hydroxyapatite to replace lost mineral content, leveraging its chemical similarity and high biocompatibility. Hydroxyapatite is a mineral and not a protein, receptor, or enzyme, and therefore is not considered a therapeutic target in the pharmacological sense; it is instead a substrate for biomaterials or restorative interventions, not a direct drug target[1][3][5].

Other names
HydroxyapatiteHydroxylapatiteCa₁₀(PO₄)₆(OH)₂Tooth mineralDental apatiteEnamel apatite
02

Mechanism of action

Null (not a direct drug target; mechanistically, exogenous HAP can promote remineralization by direct mineral deposition and occlusion of enamel micropores[1][3][5].)

03

Biological functions

Structural component of tooth enamelProvides hardness and strength to enamel and dentinPlays a role in remineralization and demineralization cycles
04

Disease associations

Dental caries (tooth decay)Enamel hypomineralizationTooth erosionOther (decalcification, formation of dental calculus)

Beyond the preview

Go deeper on Tooth hydroxyapatite (HAP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tooth hydroxyapatite (HAP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call